3rd Quarter - Report
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$341,923
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing Program, FY18 LHHS Appropriations, Proposed 2018 Outpatient Prospective Payment System Rule, Interim Final Rule Delaying Effective Dates of 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY IRVING DAVIS | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| DANA LAUREN GANSMAN New | Dir. of Scheduling & Executive Assistant, Sen. Charles Schumer; Special Assistant, Democratic Staff, Senate Committee on Rules and Administration; Volunteer Recruitment and Training Aide, Joint Congressional Committee on Inaugural Ceremonies |
| TED SLAFSKY | — |
| AMANDA SELLERS SMITH | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.